← Back to Clinical Trials
Recruiting NCT07402408

NCT07402408 Blood Flow Restriction Training in Knee Osteoarthritic Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07402408
Status Recruiting
Phase
Sponsor Riphah International University
Condition Knee Osteoarthristis
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2026-06-30
Primary Completion 2026-10-30

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Blood flow restriction training with Floss bandBlood flow restriction training with pneumatic cuff

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2026-06-30 with a primary completion date of 2026-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study was to compare the effect of band tissue flossing method and traditional cuff method for blood flow restriction training on pain, range of motion, muscle strength and functional status in patients with knee osteoarthritis. Symptoms of this condition limit patient's ability to perform high load strengthening. Blood flow restraining training allows strengthening with lower loads. 46 subjects will be divided in two groups, 23 subjects in each group. knee extension and knee press exercises will be performed. In group A floss band was tied on thigh and in group B pneumatic cuff was applied on thigh. 40-60 years individual with knee osteoarthritis will be included. outcome measures will be assessed at baseline, after 1st session, after 2nd week and after 4th week.

Eligibility Criteria

Inclusion Criteria: * Age 40-60 years * Pain more than or equal to 3 on NPRS * Range of motion ≤ 100-degree flexion and ≤ 0-degree extension * Those who have knee osteoarthritis, according to KL (Grade 1 and 2) * Genders: Male and Female Exclusion Criteria: * Cardiovascular condition e.g., hypertension, thromboembolism, lymphatic diseases etc. * Muscle/tendon/ ligament injuries * Any surgery, skin infection, trauma, pregnancy, fracture and fall * Patient with intra articular steroidal therapy with in last 6 months * Patient unwilling to participate and comply with the study session

Contact & Investigator

Central Contact

Imran Amjad, PhD

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

Muhammad Affan Iqbal, PhD*

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07402408 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Knee Osteoarthristis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07402408 currently recruiting?

Yes, NCT07402408 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07402408 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07402408 clinical trial?

NCT07402408 is sponsored by Riphah International University. The principal investigator is Muhammad Affan Iqbal, PhD* at Riphah International University. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology